Volume 1, issue 2, August 2000

14 articles in this issue

An essential guide to the literature

Authors
- William J Penny
- John P Bourke
- Content type: Editorial
- Published: 11 October 2000
- Article: 128
Gene therapy for lipid disorders

Authors
- Masa-aki Kawashiri
- Daniel J Rader
- Content type: Review
- Published: 11 October 2000
- Article: 120
Medical therapy versus interventional therapy in hypertropic obstructive cardiomyopathy

Authors
- Hubert Seggewiss
- Content type: Review
- Published: 11 October 2000
- Article: 115
Pacing in congestive heart failure

Authors
- Jayne A Morris-Thurgood
- Michael P Frenneaux
- Content type: Review
- Published: 11 October 2000
- Article: 107
Low-molecular-weight heparins in the treatment of venous thromboembolism

Authors
- Walter Ageno
- Menno V Huisman
- Content type: Review
- Published: 29 August 2000
- Article: 102
Debate: Do all patients with heart failure require implantable defibrillators to prevent sudden death?

Authors
- Henry H Hsia
- Mariell L Jessup
- Francis E Marchlinski
- Content type: Commentary
- Published: 11 October 2000
- Article: 98
Debate: Do all patients with heart failure require automatic implantable defibrillators for the prevention of sudden death?

Authors
- Sidney Goldstein
- Content type: Commentary
- Published: 11 October 2000
- Article: 95
Debate: Do all patients with heart failure require implantable defibrillators to prevent sudden death?

Authors
- Jacobus Lubsen
- Content type: Commentary
- Published: 11 October 2000
- Article: 92
Clinical applicability of molecular biology: the case of the long QT syndrome

Authors
- Peter J Schwartz
- Content type: Commentary
- Published: 11 October 2000
- Article: 88
Results of the Ticlid or Plavix Post-Stents (TOPPS) trial: do they justify the switch from ticlopidine to clopidogrel after coronary stent placement?

Authors
- Peter B Berger
- Content type: Commentary
- Published: 11 October 2000
- Article: 83
Angiotensin receptor blockers in heart failure after the ELITE II trial

Authors
- Ronnie Willenheimer
- Content type: Commentary
- Published: 12 September 2000
- Article: 79
Debate: The slippery slope of surrogate outcomes

Authors
- Ralph B D'Agostino Jr
- Content type: Commentary
- Published: 11 October 2000
- Article: 76
Debate: Are surrogate end-point studies worth the effort?

Authors
- Jonathan Valabhji
- Robert S Elkeles
- Content type: Commentary
- Published: 12 September 2000
- Article: 72
Debate: Does it matter how you lower blood pressure?

Authors
- Michael H Alderman
- Content type: Commentary
- Published: 17 August 2000
- Article: 69

Volume 1, issue 2, August 2000

An essential guide to the literature

Gene therapy for lipid disorders

Medical therapy versus interventional therapy in hypertropic obstructive cardiomyopathy

Pacing in congestive heart failure

Low-molecular-weight heparins in the treatment of venous thromboembolism

Debate: Do all patients with heart failure require implantable defibrillators to prevent sudden death?

Debate: Do all patients with heart failure require automatic implantable defibrillators for the prevention of sudden death?

Debate: Do all patients with heart failure require implantable defibrillators to prevent sudden death?

Clinical applicability of molecular biology: the case of the long QT syndrome

Results of the Ticlid or Plavix Post-Stents (TOPPS) trial: do they justify the switch from ticlopidine to clopidogrel after coronary stent placement?

Angiotensin receptor blockers in heart failure after the ELITE II trial

Debate: The slippery slope of surrogate outcomes

Debate: Are surrogate end-point studies worth the effort?

Debate: Does it matter how you lower blood pressure?

For authors

Explore

Navigation

Volume 1, issue 2, August 2000

Authors

Authors

Authors

Authors

Authors

Authors

Authors

Authors

Authors

Authors

Authors

Authors

Authors

Authors

For authors

Explore

Search

Navigation